PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation announced the appointment of Meredith Manning to President of the Americas, effective immediately. In this new scope, Ms. Manning will be supported by her U.S. leadership team to evaluate potential commercial strategies and partnerships to reach MPN patient communities throughout the American continents, with a near-term focus on Canada and Latin America.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
467.5 TWD | +8.72% | +9.87% | +35.12% |
05-27 | Pharmaessentia Corporation Announces Term Expiration of Their Fourth Remuneration Committee | CI |
05-27 | Pharmaessentia Corporation Announces Changes to Members of Third Audit Committee | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+35.12% | 4.41B | |
+18.72% | 123B | |
+14.53% | 107B | |
-2.88% | 24.01B | |
+2.18% | 22.59B | |
-10.09% | 18.16B | |
-41.04% | 16.84B | |
-11.83% | 16.23B | |
+1.46% | 13.43B | |
+24.22% | 11.32B |
- Stock Market
- Equities
- 6446 Stock
- News PharmaEssentia Corporation
- PharmaEssentia Corporation's Subsidiary PharmaEssentia USA Corporation Appoints Meredith Manning to President of the Americas